Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Breast 1

Conditions

Breast Neoplasms 17Ovarian Neoplasms 4Sarcoma 3Pancreatic Neoplasms 3Neoplasms 3Melanoma 3Carcinoma, Renal Cell 3Carcinoma, Non-Small-Cell Lung 3Neoplasm Metastasis 2Lung Neoplasms 2Head and Neck Neoplasms 2Gastrointestinal Neoplasms 2Breast Neoplasms, Male 2Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor - Protocol Specific 1Thyroid Neoplasms 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Inflammatory Breast Neoplasms 1Hypertension 1Glioblastoma 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Central Nervous System Neoplasms 1

Interventions

pazopanib 1Paclitaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unspecified Adult Solid Tumor - Protocol Specific × pazopanib × Breast × Clear all
NCT01407562 2022-09-28

Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors

Rutgers, The State University of New Jersey

Phase 1 Terminated
34 enrolled
BreastOther solid neoplasm

Unspecified Adult Solid Tumor - Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡